Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis

Toxicol Appl Pharmacol. 2007 May 1;220(3):302-10. doi: 10.1016/j.taap.2007.02.011. Epub 2007 Feb 24.

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is an inflammatory cytokine that modulates osteoblastogenesis. In addition, the demonstrated inhibitory effects of chronic ethanol exposure on direct bone formation in rats are hypothetically mediated by TNF-alpha signaling. The effects in mice are unreported. Therefore, we hypothesized that in mice (1) administration of a soluble TNF receptor 1 derivative (sTNF-R1) would protect direct bone formation during chronic ethanol exposure, and (2) administration of recombinant mouse TNF-alpha (rmTNF-alpha) to ethanol naïve mice would inhibit direct bone formation. We utilized a unique model of limb lengthening (distraction osteogenesis, DO) combined with liquid diets to measure chronic ethanol's effects on direct bone formation. Chronic ethanol exposure resulted in increased marrow TNF, IL-1, and CYP 2E1 RNA levels in ethanol-treated vs. control mice, while no significant weight differences were noted. Systemic administration of sTNF-R1 during DO (8.0 mg/kg/2 days) to chronic ethanol-exposed mice resulted in enhanced direct bone formation as measured radiologically and histologically. Systemic rmTNF-alpha (10 microg/kg/day) administration decreased direct bone formation measures, while no significant weight differences were noted. We conclude that chronic ethanol-associated inhibition of direct bone formation is mediated to a significant extent by the TNF signaling axis in a mouse model.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / metabolism
  • Central Nervous System Depressants / administration & dosage
  • Central Nervous System Depressants / pharmacology
  • Cytochrome P-450 CYP2E1 / genetics
  • Cytochrome P-450 CYP2E1 / metabolism
  • Ethanol / administration & dosage
  • Ethanol / blood
  • Ethanol / pharmacology*
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Models, Animal
  • Osteogenesis / drug effects
  • Osteogenesis / physiology
  • Osteogenesis, Distraction / methods*
  • Osteotomy / methods
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Tumor Necrosis Factor / antagonists & inhibitors
  • Recombinant Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Signal Transduction*
  • TNF Receptor-Associated Factor 1 / metabolism
  • TNF Receptor-Associated Factor 1 / pharmacology
  • Tibia / surgery
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Central Nervous System Depressants
  • Interleukin-6
  • RNA, Messenger
  • Receptors, Tumor Necrosis Factor
  • Recombinant Proteins
  • TNF Receptor-Associated Factor 1
  • Tumor Necrosis Factor-alpha
  • Ethanol
  • Cytochrome P-450 CYP2E1